FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2604360116> ?p ?o ?g. }

• W2604360116 abstract "You have accessJournal of UrologyUrodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Neurogenic Voiding Dysfunction I1 Apr 2017MP85-17 FACTORS ASSOCIATED WITH DURABILITY OF THERAPEUTIC BOTULINUM TOXIN A INJECTION FOR OVERACTIVE BLADDER Kristian Stensland, Jay Vance, Bennett Sluis, Jared Schober, Arthur Mourtzinos, and Lara Maclachlan Kristian StenslandKristian Stensland More articles by this author , Jay VanceJay Vance More articles by this author , Bennett SluisBennett Sluis More articles by this author , Jared SchoberJared Schober More articles by this author , Arthur MourtzinosArthur Mourtzinos More articles by this author , and Lara MaclachlanLara Maclachlan More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.2679AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Patients suffering from overactive bladder (OAB) without response to behavioral and pharmaceutical intervention may opt for third-line therapy with botulinum toxin A injection. Botulinum injections have shown success in treating OAB urinary symptoms, but require repeat injections at an interval of 4-12 months. This study seeks to identify factors associated with the durability of this therapeutic effect. METHODS Patients undergoing treatment for OAB at Lahey Hospital and Medical Center between 2004 and 2016 were identified. Demographic, clinical and treatment data were extracted from patient charts. Patients were included if they had at least 1 botulinum injections. Time from initial to second botulinum injection was defined as therapeutic durability; time from initial injection to last clinic follow-up was defined and time to event analyses were employed: univariate analysis via log-rank method and multivariate Cox proportional hazards were used to identify associations with therapeutic durability. The multivariate Cox model comprised univariate factors with p values below 0.1 and a priori clinical variables. Significance was defined at the a= 0.05 level. RESULTS Of the available patients, 54 patients met inclusion criteria. Median time to repeat injection for those who had a second injection was 259 days (8.6 months). Kaplan-Meier survival estimated that 50% of patients required reinjection at 330 days (11 months). On univariate analysis, history of spinal cord injury (p = 0.041), prostate cancer (p < 0.001), history of stroke/CVA (p=0.037), and history of UTI (p=0.013) were significantly associated with lower therapeutic durability. On multivariate analysis, only prostate cancer (OR 50.2, 95% CI 2.95-854, p = 0.0068) and history of UTI (OR 4.11, 95% CI 1.10-15.3, p = 0.035) were associated with lower therapeutic durability. CONCLUSIONS Botulinum injection showed a median durability of roughly 9 months. Patients with prostate cancer or a history of UTI had a statistically significantly lower durability of botulinum injection. Further study is warranted to identify further etiologic origins of these connections or elucidate other associated cofactors. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e1154 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Kristian Stensland More articles by this author Jay Vance More articles by this author Bennett Sluis More articles by this author Jared Schober More articles by this author Arthur Mourtzinos More articles by this author Lara Maclachlan More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ..." @default.
• W2604360116 created "2017-04-14" @default.
• W2604360116 creator A5008072553 @default.
• W2604360116 creator A5039442117 @default.
• W2604360116 creator A5061244538 @default.
• W2604360116 creator A5069772656 @default.
• W2604360116 creator A5076298541 @default.
• W2604360116 creator A5087309211 @default.
• W2604360116 date "2017-04-01" @default.
• W2604360116 modified "2023-10-15" @default.
• W2604360116 title "MP85-17 FACTORS ASSOCIATED WITH DURABILITY OF THERAPEUTIC BOTULINUM TOXIN A INJECTION FOR OVERACTIVE BLADDER" @default.
• W2604360116 doi "https://doi.org/10.1016/j.juro.2017.02.2679" @default.
• W2604360116 hasPublicationYear "2017" @default.
• W2604360116 type Work @default.
• W2604360116 sameAs 2604360116 @default.
• W2604360116 citedByCount "0" @default.
• W2604360116 crossrefType "journal-article" @default.
• W2604360116 hasAuthorship W2604360116A5008072553 @default.
• W2604360116 hasAuthorship W2604360116A5039442117 @default.
• W2604360116 hasAuthorship W2604360116A5061244538 @default.
• W2604360116 hasAuthorship W2604360116A5069772656 @default.
• W2604360116 hasAuthorship W2604360116A5076298541 @default.
• W2604360116 hasAuthorship W2604360116A5087309211 @default.
• W2604360116 hasBestOaLocation W26043601161 @default.
• W2604360116 hasConcept C126322002 @default.
• W2604360116 hasConcept C126894567 @default.
• W2604360116 hasConcept C141071460 @default.
• W2604360116 hasConcept C142724271 @default.
• W2604360116 hasConcept C204787440 @default.
• W2604360116 hasConcept C2777478456 @default.
• W2604360116 hasConcept C2778941218 @default.
• W2604360116 hasConcept C71924100 @default.
• W2604360116 hasConceptScore W2604360116C126322002 @default.
• W2604360116 hasConceptScore W2604360116C126894567 @default.
• W2604360116 hasConceptScore W2604360116C141071460 @default.
• W2604360116 hasConceptScore W2604360116C142724271 @default.
• W2604360116 hasConceptScore W2604360116C204787440 @default.
• W2604360116 hasConceptScore W2604360116C2777478456 @default.
• W2604360116 hasConceptScore W2604360116C2778941218 @default.
• W2604360116 hasConceptScore W2604360116C71924100 @default.
• W2604360116 hasIssue "4S" @default.
• W2604360116 hasLocation W26043601161 @default.
• W2604360116 hasOpenAccess W2604360116 @default.
• W2604360116 hasPrimaryLocation W26043601161 @default.
• W2604360116 hasRelatedWork W1969146667 @default.
• W2604360116 hasRelatedWork W1980265965 @default.
• W2604360116 hasRelatedWork W2070559814 @default.
• W2604360116 hasRelatedWork W2283448968 @default.
• W2604360116 hasRelatedWork W2624543393 @default.
• W2604360116 hasRelatedWork W2767918166 @default.
• W2604360116 hasRelatedWork W3168669826 @default.
• W2604360116 hasRelatedWork W4242074381 @default.
• W2604360116 hasRelatedWork W4248466144 @default.
• W2604360116 hasRelatedWork W3029151527 @default.
• W2604360116 hasVolume "197" @default.
• W2604360116 isParatext "false" @default.
• W2604360116 isRetracted "false" @default.
• W2604360116 magId "2604360116" @default.
• W2604360116 workType "article" @default.